RxDoctor Payments Data

Michael Huang

Psychiatric/Mental Health · Concord, MANPI 1548716004

Payments from drug & device makers

$1,136in general payments, 2019–2025

Across 51 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$330
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$162
  • Gilead$161
  • Vanda Pharmaceuticals Inc.$98
  • AbbVie$72
  • Indivior Inc.$63
  • plus $251 from 8 others

What the payments were for

  • Food & beverage$1,136100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,136 in reported general payments places this provider in the 75th percentile of 1,284 psychiatric/mental health providers in Massachusetts.

See all psychiatric/mental health providers in Massachusetts

Medicare billing

Part B allowed, 2024
$7,308
Medicare patients
20
Services billed
129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole26$76,350
CaplytaLumateperone Tosylate12$20,244
Lamotrigine ErLamotrigine19$1,775
Aripiprazole15$1,539
Atomoxetine Hcl11$1,358
Guanfacine Hcl19$915
Ziprasidone Hcl17$851
Clonazepam77$814
Gabapentin41$638
Trazodone Hcl38$632
LoxapineLoxapine Succinate13$605
Risperidone25$559
Buspirone Hcl24$554
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine15$505
Mirtazapine19$367

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$61$76,35026 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$162$20,24412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,284 psychiatric/mental health providers in Massachusetts.

Other psychiatric/mental health in Concord

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →